Skip to main navigation
Skip to search
Skip to main content
Sort by
Medicine and Dentistry
Hepatocellular Carcinoma
93%
Hepatitis B Virus
21%
Living Donor
18%
Overall Survival
16%
Immune Checkpoint Inhibitor
15%
Recurrent Disease
14%
Neoplasm
13%
Kidney Graft
12%
Allograft
10%
Tumor Thrombus
9%
Hepatocyte
9%
Carcinogenesis
9%
Nephrectomy
8%
Effective Kidney Plasma Flow
8%
Liver Transplantation
8%
Transcatheter Arterial Chemoembolization
8%
Quality Adjusted Life Year
8%
Computer Assisted Tomography
8%
Malignant Neoplasm
8%
Hepatitis B
7%
Surgical Technique
7%
Liver Cancer
6%
Liver Tumor
6%
Laparoscopic Surgery
6%
Macrophage
6%
Liver Function
6%
Multivariate Analysis
6%
Recurrence Free Survival
6%
Metastatic Carcinoma
5%
Diseases
5%
Renal Artery
5%
Phosphotransferase
5%
Meta-Analysis
5%
Embolization
5%
Immunotherapy
5%
Propensity Score Matching
5%
Hazard Ratio
5%
Sorafenib
5%
Surgical Margin
5%
Biological Marker
5%
Pharmacology, Toxicology and Pharmaceutical Science
Liver Cell Carcinoma
100%
Recurrent Disease
21%
Hepatitis B Virus
21%
Immune Checkpoint Inhibitor
18%
Overall Survival
13%
Carcinogenesis
13%
Liver Cancer
11%
Sorafenib
10%
Programmed Death 1 Receptor
10%
Tumor Thrombus
9%
Neoplasm
9%
Malignant Neoplasm
8%
Ciclosporin
8%
Transgenic Mouse
7%
Diseases
7%
Hepatitis B
7%
Immunotherapy
5%
Life Expectancy
5%
Hepatitis B Virus X Protein
5%
Liver Carcinogenesis
5%
Adverse Event
5%
Keyphrases
Hepatocellular Carcinoma
13%
Taiwan
8%
Liver Transplantation
6%
Colorectal Cancer Patients
5%
Liver
5%
